NFKB1 and cancer: ,33,39 The secreted LIGHT is able to bind lymphotoxin-β receptor on stromal cells, such as cancer-associated fibroblasts (CAFs) and vascular endothelial cells, facilitating chemokine gradient formation predominantly through activation of the non-canonical nuclear factor κB (NF-κB) signaling pathway.40